Valuation Becton, Dickinson and Company Deutsche Boerse AG

Stocks

Real-time Estimate Tradegate 03:57:23 14/08/26 am AEST			5-day change	1st Jan Change
158.15 ^EUR	+1.05%		+6.60%	-2.90%

02:00am	Becton, Dickinson's Consistent Mid-Single-Digit Organic Growth is 12-18 Months Away, RBC Says	MT
09:59pm	Citigroup Adjusts Price Target on Becton Dickinson and Co. to $208 From $204, Maintains Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: September	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	70,597	63,550	75,002	69,688	53,648	50,005	-	-
Change	-	-9.98%	18.02%	-7.08%	-23.02%	-6.79%	-	-
Enterprise Value (EV) ¹	85,924	78,609	89,465	88,081	72,188	65,890	63,956	62,190
Change	-	-8.51%	13.81%	-1.55%	-18.04%	-8.73%	-2.93%	-2.76%
P/E	35.9x	37.9x	52.3x	40.7x	32.2x	37.9x	22.2x	19.3x
PBR	2.95x	3.21x	3.71x	2.69x	2.1x	1.95x	1.84x	1.75x
PEG	-	-2.7x	-3.3x	2x	-17.36x	-2.2x	0.3x	1.3x
Capitalization / Revenue	3.49x	3.37x	3.87x	3.44x	2.46x	2.59x	2.53x	2.43x
EV / Revenue	4.24x	4.17x	4.62x	4.35x	3.31x	3.42x	3.24x	3.03x
EV / EBITDA	14.7x	15.2x	13.1x	12.4x	12x	11.7x	11.1x	10.2x
EV / EBIT	17.3x	18x	19.6x	18.3x	13.2x	13.6x	13x	12x
EV / FCF	25.2x	52.5x	42.3x	28.2x	27x	20.8x	24x	22.2x
FCF Yield	3.98%	1.91%	2.37%	3.54%	3.7%	4.8%	4.16%	4.5%
Dividend per Share ²	3.32	3.48	3.64	3.8	4.16	3.924	3.991	3.993
Rate of return	1.35%	1.56%	1.41%	1.58%	2.22%	2.14%	2.17%	2.18%
EPS ²	6.85	5.88	4.94	5.93	5.82	4.839	8.251	9.519
Distribution rate	48.5%	59.2%	73.7%	64.1%	71.5%	81.1%	48.4%	42%
Net sales ¹	20,248	18,870	19,372	20,245	21,840	19,291	19,734	20,546
EBITDA ¹	5,838	5,160	6,846	7,099	6,028	5,628	5,759	6,087
EBIT ¹	4,971	4,362	4,558	4,813	5,468	4,833	4,938	5,199
Net income ¹	2,002	1,689	1,424	1,726	1,678	1,362	2,157	2,456
Net Debt ¹	15,327	15,059	14,463	18,393	18,540	15,885	13,952	12,185
Reference price ²	245.82	222.83	258.53	241.10	187.17	183.58	183.58	183.58
Nbr of stocks (in thousands)	287,190	285,195	290,109	289,042	286,627	272,387	-	-
Announcement Date	4/11/21	10/11/22	9/11/23	7/11/24	6/11/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (N)	EV / Sales (N)	EV / EBITDA (N)	Dividend Yield (N)	Capi.($)
ABBOTT LABORATORIES	31.83x	4.29x	16.61x	2.32%	192B
MEDTRONIC PLC	20.57x	3.56x	12.52x	3.28%	116B
CENCORA, INC.	17.2x	0.2x	12.44x	0.76%	59.95B
HOYA CORPORATION	31.77x	7.93x	20.18x	1.25%	54.64B
BECTON, DICKINSON AND COMPANY	37.93x	3.42x	11.71x	2.14%	50B
DEXCOM, INC.	36.4x	6.41x	20.11x	-.--%	34.26B
MEDLINE INC.	46.2x	1.31x	12.01x	0.16%	31.15B
WEST PHARMACEUTICAL SERVICES, INC.	41.08x	7.2x	25.83x	0.26%	24.79B
TERUMO CORPORATION	20.67x	3.12x	11.69x	1.41%	24.07B
Average	31.52x	4.16x	15.90x	1.29%	65.22B
Weighted average by Cap.	29.58x	4.03x	15.44x	1.86%